| Dr Jerome Andrew Kessler, MD | |
|
214 14th Ave Sw, Sidney, MT 59270-3521 | |
| (406) 488-2550 | |
| (406) 488-2278 |
| Full Name | Dr Jerome Andrew Kessler |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 44 Years |
| Location | 214 14th Ave Sw, Sidney, Montana |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942551106 | NPI | - | NPPES |
| M011003722 | Other | MT | NORIDIAN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sidney Health Center | Sidney, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sidney Health Center | 0749181535 | 63 |
News Archive
Novela Neurotech, a medtech company at the forefront of accelerating novel neurological therapies through neural data curation, collaboration and sharing, is excited to join INCF's Industry Advisory Council to help guide efforts at industry and academic collaborations in the neuroscience, data science and neurotech sphere.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
MedThink Communications, a full-service healthcare communications company, today announced the launch of MedThink Connect™, a new, customizable Web application that provides healthcare companies a vehicle to efficiently seek guidance, maintain interaction, and build a community atmosphere with external experts. MedThink Connect allows users to advance their relationships with external experts, including advisors, investigators, spokespeople, patients, and speakers.
MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies with a stake in the market for rheumatology therapies, including rheumatoid arthritis (RA) and lupus.
› Verified 8 days ago
| Entity Name | Northern Montana Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427059070 PECOS PAC ID: 2264343912 Enrollment ID: O20031229000278 |
News Archive
Novela Neurotech, a medtech company at the forefront of accelerating novel neurological therapies through neural data curation, collaboration and sharing, is excited to join INCF's Industry Advisory Council to help guide efforts at industry and academic collaborations in the neuroscience, data science and neurotech sphere.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
MedThink Communications, a full-service healthcare communications company, today announced the launch of MedThink Connect™, a new, customizable Web application that provides healthcare companies a vehicle to efficiently seek guidance, maintain interaction, and build a community atmosphere with external experts. MedThink Connect allows users to advance their relationships with external experts, including advisors, investigators, spokespeople, patients, and speakers.
MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies with a stake in the market for rheumatology therapies, including rheumatoid arthritis (RA) and lupus.
› Verified 8 days ago
| Entity Name | Sidney Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376617191 PECOS PAC ID: 0749181535 Enrollment ID: O20040115000513 |
News Archive
Novela Neurotech, a medtech company at the forefront of accelerating novel neurological therapies through neural data curation, collaboration and sharing, is excited to join INCF's Industry Advisory Council to help guide efforts at industry and academic collaborations in the neuroscience, data science and neurotech sphere.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
MedThink Communications, a full-service healthcare communications company, today announced the launch of MedThink Connect™, a new, customizable Web application that provides healthcare companies a vehicle to efficiently seek guidance, maintain interaction, and build a community atmosphere with external experts. MedThink Connect allows users to advance their relationships with external experts, including advisors, investigators, spokespeople, patients, and speakers.
MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies with a stake in the market for rheumatology therapies, including rheumatoid arthritis (RA) and lupus.
› Verified 8 days ago
| Entity Name | Wolf Point Clinic Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992722904 PECOS PAC ID: 3678546660 Enrollment ID: O20040817001372 |
News Archive
Novela Neurotech, a medtech company at the forefront of accelerating novel neurological therapies through neural data curation, collaboration and sharing, is excited to join INCF's Industry Advisory Council to help guide efforts at industry and academic collaborations in the neuroscience, data science and neurotech sphere.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
MedThink Communications, a full-service healthcare communications company, today announced the launch of MedThink Connect™, a new, customizable Web application that provides healthcare companies a vehicle to efficiently seek guidance, maintain interaction, and build a community atmosphere with external experts. MedThink Connect allows users to advance their relationships with external experts, including advisors, investigators, spokespeople, patients, and speakers.
MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies with a stake in the market for rheumatology therapies, including rheumatoid arthritis (RA) and lupus.
› Verified 8 days ago
| Entity Name | Sidney Health Center |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1285719161 PECOS PAC ID: 0749181535 Enrollment ID: O20061104000419 |
News Archive
Novela Neurotech, a medtech company at the forefront of accelerating novel neurological therapies through neural data curation, collaboration and sharing, is excited to join INCF's Industry Advisory Council to help guide efforts at industry and academic collaborations in the neuroscience, data science and neurotech sphere.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
MedThink Communications, a full-service healthcare communications company, today announced the launch of MedThink Connect™, a new, customizable Web application that provides healthcare companies a vehicle to efficiently seek guidance, maintain interaction, and build a community atmosphere with external experts. MedThink Connect allows users to advance their relationships with external experts, including advisors, investigators, spokespeople, patients, and speakers.
MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies with a stake in the market for rheumatology therapies, including rheumatoid arthritis (RA) and lupus.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jerome Andrew Kessler, MD 214 14th Ave Sw, Sidney, MT 59270-3521 Ph: (406) 488-2550 | Dr Jerome Andrew Kessler, MD 214 14th Ave Sw, Sidney, MT 59270-3521 Ph: (406) 488-2550 |
News Archive
Novela Neurotech, a medtech company at the forefront of accelerating novel neurological therapies through neural data curation, collaboration and sharing, is excited to join INCF's Industry Advisory Council to help guide efforts at industry and academic collaborations in the neuroscience, data science and neurotech sphere.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
MedThink Communications, a full-service healthcare communications company, today announced the launch of MedThink Connect™, a new, customizable Web application that provides healthcare companies a vehicle to efficiently seek guidance, maintain interaction, and build a community atmosphere with external experts. MedThink Connect allows users to advance their relationships with external experts, including advisors, investigators, spokespeople, patients, and speakers.
MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies with a stake in the market for rheumatology therapies, including rheumatoid arthritis (RA) and lupus.
› Verified 8 days ago
Dr. Aaron John Franke, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 216 14th Ave Sw, Sidney, MT 59270 Phone: 406-488-2504 | |
Dr. Robert Harold Joseph, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 216 14th Ave Sw, Sidney, MT 59270 Phone: 406-488-2100 | |
Chad A Pedersen, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 214 14th Ave Sw, Sidney, MT 59270 Phone: 406-488-2504 | |
Edward Lewis Pierce, MD PC Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 214 14th Ave Sw, Suite 112, Sidney, MT 59270 Phone: 406-488-2231 Fax: 406-488-2520 |